The first MM+M/Publicis Health Pharma Marketing Transformation Survey suggests that, despite progress, pharma has only scratched the surface of digitally enabling the marketing function.
Pipeline Report 2023: Game on for blockbusters, novel MOAs and practice-changing drugs
The industry awaits a number of readouts and approvals for drugs that address market gaps and enrich treatment landscapes — with huge sales potential to boot.
Innovating at the point-of-care: Combining direct and programmatic ad buying in the EHR
Through strategic collaborations between Veradigm and industry leading demand side platforms (DSPs), marketers have the option to buy EHR inventory both directly and programmatically.
AI Deciphered: Discovering the Potential for Marketers and Communicators